Stakeholder Vaccine FAQ, from the Department of Health and Social Care Please note that text that is highlighted blue has been updated on 6 August by the Department of Health and Social Care. Contents Top lines ........................................................................................................................................................................................ 2 Vaccine deployment statistics ........................................................................................................................................ 2 Top announcements and lines in the last seven days: .................................................................................... 3 Q&A ................................................................................................................................................................................................. 13 Boosters ........................................................................................................................................................................................ 13 Blood clots and the Oxford/AstraZeneca vaccine ................................................................................................ 14 Which vaccines have been authorised in the UK? ................................................................................................ 16 Research, Development and Manufacturing ........................................................................................................... 16 Details on specific vaccines/manufacturers ............................................................................................................ 17 ‘Mix and Match’, Heterologous Prime Boost ........................................................................................................... 22 Vaccine quantities in the UK, availability of supply ............................................................................................ 23 Vaccine Roll Out ...................................................................................................................................................................... 24 Disabilities and vaccine ....................................................................................................................................................... 25 Immunocompromised people ........................................................................................................................................ 26 People who are homeless or rough sleepers ......................................................................................................... 28 Children ....................................................................................................................................................................................... 29 Time between first dose and second dose, changes to dosage interval ................................................. 31 New variants and vaccine effectiveness ................................................................................................................... 32 Vaccine efficacy, length of protection, impact on transmissibility, deaths prevented ................... 36 Vigilance, side effects and adverse incidents ......................................................................................................... 38 Vaccines as a condition of deployment .................................................................................................................... 40 BAME uptake ............................................................................................................................................................................. 41 Working with businesses and the private sector ................................................................................................. 43 COVID-Status certification review (so-called ‘vaccine passports’) ............................................................. 43 Vaccine Passports, International Travel .................................................................................................................... 45 Clinical trials .............................................................................................................................................................................. 47 Ingredients, Controversial Substances, Moral and Ethical Advisory Group (MEAG) ........................ 48 Pregnancy, childbirth, fertility ......................................................................................................................................... 49 Vaccine hesitancy, misinformation, disinformation ........................................................................................... 52 Community Champions scheme (updated 25/01/2021) ................................................................................... 53 Top lines Vaccines are the way out of this pandemic. Vaccines are the best way to protect people from coronavirus and have saved thousands of lives. Vaccinated people are far less likely to get COVID with symptoms. Vaccinated people are even more unlikely to get serious COVID-19, to be admitted to hospital, or to die from it and vaccinated people are less likely to pass the virus to others. The first dose of the vaccine offers good levels of protection, but to get maximum protection everyone must get a second dose, so we are urging all people to come back when they are contacted or if they have an appointment booked. 46.9 million people have now received their first COVID-19 vaccine dose. 39 million have had their second dose. All those aged 18 and over can book their vaccination through the NHS booking service. You can also call 119 free of charge, anytime between 7am and 11pm seven days a week. All adults should have a chance to have a second dose by mid September All 16-and-17-year olds will be offered the vaccine. Initially they should wait to be contacted by their GP to arrange an appointment although walk-in services will soon be available. Children aged 12 to 15 who are clinically vulnerable to COVID or live with adults who are at increased risk of serious illness from the virus will be contacted by the NHS and invited for their vaccine shortly. From 19 July, arrivals who have received two doses of an NHS administered COVID-19 vaccine in the UK (plus 14 days), or are on a formally approved UK vaccine clinical trial, returning to England from amber list counties will no longer need to quarantine From 16 August, people who have received two doses of COVID-19 vaccine will no longer need to self-isolate if they are identified as a close contact of someone with COVID-19. You can book via the NHS website here: https://www.nhs.uk/conditions/coronavirus- covid-19/coronavirus-vaccination/book-coronavirus-vaccination/ The Covid-19 vaccination programme is the biggest vaccination programme in NHS history. Vaccine deployment statistics Latest number on vaccines can be found on the gov.uk coronavirus dashboard here. NHS.uk statistics, updated weekly, can be found here. Total vaccination statistics - up to and including 5 August 2021: UK total first dose: 46,961,830 UK total second dose: 39,047,529 1st dose 2nd dose Total England 39,416,306 32,588,410 72,004,716 1st dose 2nd dose Total Scotland 4,020,712 3,286,153 7,306,865 Wales 2,300,137 2,099,624 4,399,761 Northern Ireland 1,224,675 1,073,342 2,298,017 Top announcements and lines in the last seven days: NHS release - One million children and young people can get NHS COVID jab (06.08.21) More than a million children and young people can get the COVID jab in the latest stage of the NHS vaccination programme, the biggest and most successful in health service history. The NHS has worked to rapidly extend the programme to 16 and 17 year olds, the country’s most vulnerable children and those who live with vulnerable adults following changes in guidance from the Joint Committee on Vaccination and Immunisation (JCVI). All 16-and-17-year olds will be offered one jab dose of the vaccine, under the new guidance issued by the JCVI earlier this week. Initially, they should wait to be contacted by their GP to arrange an appointment although walk-in services will soon be available to everyone aged 16 and over. While children and young people can get coronavirus, there are fewer cases compared to adults and symptoms are usually mild. Dr Nikki Kanani, NHS medical director for primary care and deputy SRO for the vaccine programme said : “NHS staff have delivered 70 million COVID-19 vaccines across England in just over seven months, giving protection against coronavirus to more than 39 million people and saving thousands of lives. “The NHS has also worked hard to put the JCVI guidance into action as swiftly as possible and I am pleased to say that one million children and young people will now be able to get the vaccine, protecting themselves, their family and their friends. “The COVID-19 vaccine is safe and effective and I urge anyone eligible of any age to come forward and take up the offer.” Health and Social Care Secretary, Sajid Javid said : “COVID-19 vaccines have saved more than 60,000 lives and prevented 22 million infections in England alone. They are building a wall of defence against the virus and are the best way to protect people from serious illness. “The NHS have worked hard to put the JCVI’s independent and expert advice into action to roll out this new stage of our ground breaking vaccination